XSHE
001217
Market cap561mUSD
Oct 09, Last price
11.34CNY
1D
0.18%
1Q
32.01%
IPO
-31.56%
Name
Anhui Huaertai Chemical Co Ltd
Chart & performance
P/E
—
P/S
1.82
EPS
—
Div yield, %
0.88%
Shrs. gr., 5y
4.22%
Rev. gr., 5y
1.81%
Revenues
2.07b
+26.24%
Net income
-29m
L
CFO
194m
-55.39%
Dividend
May 26, 20260.1 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Anhui Huaertai Chemical Co., Ltd. primarily focuses on the innovation, manufacturing, and commercialization of a diverse array of chemical substances. Their extensive catalog includes essential industrial chemicals such as ammonium sulfate, hydrogen peroxide, 65 niacin, sulfur trioxide, and melamine. Additionally, the company supplies concentrated sulfuric and nitric acids, oleum, industrial-grade sodium nitrite and nitrate, liquid ammonia, ammonium bicarbonate, and methanol. This enterprise, founded in 2000, has its operational base located in Chizhou, China.
Key people
Aozhou Wu
Vice Chairman of the Board, Staff Elected Director · since 2025
Yuyin Xu
General Manager-Fertiliser Division · since 2020
Jingfa Xu
General Manager-Refining Division · since 2022
Gensong Xu
General Manager-Chemical Division · since 2009
Yuxi Chen
General Manager, Director · since 2009
Zhuoyin Yang
Deputy General Manager, General Manager-Thermal Power Division · since 2019
Youren Chen
Director · since 2024
Kongbin Wang
Chief Engineer, Director · since 2009
Wei Wu
Chairman of the Board · since 2024
Runliang Zhou
Chief EHS Officer, Director · since 2021
Guifa Zhu
Director · since 2017
Haichuan Hu
Independent Director · since 2024
Yaohui Lou
Independent Director · since 2024
Zhiwu Qiao
Independent Director · since 2024
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||